BEI
PFE icon

Benjamin Edwards Inc’s Pfizer PFE Stock Holding History

Benjamin Edwards Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72M Buy
237,703
+35,243
+17% +$922K 0.05% 323
2026
Q1 		$5.69M Buy
202,460
+53,280
+36% +$1.42M 0.06% 304
2025
Q4 		$3.71M Buy
149,180
+14,296
+11% +$361K 0.04% 368
2025
Q3 		$3.44M Buy
134,884
+15,786
+13% +$390K 0.04% 381
2025
Q2 		$2.89M Sell
119,098
-26,428
-18% -$616K 0.04% 380
2025
Q1 		$3.69M Buy
145,526
+22,257
+18% +$582K 0.05% 309
2024
Q4 		$3.27M Sell
123,269
-116,989
-49% -$3.17M 0.05% 342
2024
Q3 		$6.95M Buy
240,258
+224,240
+1,400% +$6.54M 0.1% 214
2024
Q2 		$448K Sell
16,018
-314
-2% -$8.64K 0.09% 234
2024
Q1 		$453K Sell
16,332
-2,959
-15% -$82.1K 0.09% 231
2023
Q4 		$555K Buy
19,291
+327
+2% +$9.88K 0.12% 194
2023
Q3 		$629K Buy
18,964
+1,534
+9% +$54.2K 0.15% 155
2023
Q2 		$639K Sell
17,430
-1,628
-9% -$63.4K 0.15% 154
2023
Q1 		$778K Sell
19,058
-4,002
-17% -$173K 0.19% 143
2022
Q4 		$1.18M Buy
23,060
+993
+4% +$47.6K 0.31% 97
2022
Q3 		$966K Buy
22,067
+501
+2% +$24.3K 0.29% 107
2022
Q2 		$1.13M Sell
21,566
-1,276
-6% -$65K 0.33% 92
2022
Q1 		$1.18M Buy
22,842
+4,346
+23% +$225K 0.34% 84
2021
Q4 		$1.09M Buy
18,496
+15,415
+500% +$764K 0.35% 82
2021
Q3 		$133K Buy
3,081
+2,020
+190% +$89.5K 0.08% 207
2021
Q2 		$42K Buy
1,061
+62
+6% +$2.41K 0.03% 284
2021
Q1 		$36K Buy
999
+267
+36% +$9.48K 0.03% 269
2020
Q4 		$27K Sell
732
-38
-5% -$1.39K 0.02% 282
2020
Q3 		$27K Sell
770
-12,772
-94% -$448K 0.02% 262
2020
Q2 		$420K Buy
13,542
+12,480
+1,175% +$424K 0.35% 94
2020
Q1 		$33K Buy
1,062
+353
+50% +$12K 0.03% 198
2019
Q4 		$26K Buy
709
+235
+50% +$8.37K 0.05% 157
2019
Q3 		$16K Buy
+474
New +$17.2K 0.03% 184

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Benjamin Edwards Inc's PFE Position: Q2 2026 in Review

Benjamin Edwards Inc increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $922K and bringing the position to 237,703 shares worth $5.72M. The position accounts for 0.05% of the portfolio, ranked #323.

Benjamin Edwards Inc first reported a position in PFE in Q3 2019 and has held it in 28 quarters since. The position peaked at $6.95M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Benjamin Edwards Inc held 237,703 shares of Pfizer worth $5.72M as of Q2 2026.
  • Benjamin Edwards Inc bought 35,243 Pfizer shares in Q2 2026, an estimated $922K.
  • Pfizer made up 0.05% of Benjamin Edwards Inc's portfolio in Q2 2026, its #323 holding.
  • Benjamin Edwards Inc first reported a position in Pfizer in Q3 2019 and has held it in 28 quarters since.
  • Benjamin Edwards Inc's Pfizer position peaked at $6.95M in Q3 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.